Intermediate for Pomalidomide. Pomalidomide is a derivative of thalidomide. It is anti-angiogenic and also acts as an immunomodulator. Pomalidomide has been approved on February 28, 2013 by the U.S. Food and Drug Administration (FDA) as a treatment for relapsed and refractory multiple myeloma.
Product Name: 3-Amino-2,6-piperidinedione hydrochloride
CAS Number: 24666-56-6
Molecular Weight:  164.5913
Molecular Formula:  C5H9ClN2O2
Purity (HPLC): ≥95%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.